Form 1-K/A — 20/20 Biolabs, Inc.
0001213900-25-123375 · filed Dec 18, 2025
https://biolabs.io
(possible website — auto-inferred, not verified)
Offering
- Total offering
- —
- Total sold
- —
- Security type
- —
- Price per security
- —
- Over-allotment
- —
- Jurisdictions
- —
Issuer
- CIK
- 1139685
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877
Most recent fiscal year financials
Reg A+ Tier 2 financials are audited (1-A, 1-K). Tier 1 are reviewed.
- Total assets
- —
- Total liabilities
- —
- Cash
- —
- Total revenues
- —
- Net income
- —
Same issuer's Form D filings
-
D · Feb 26, 2025$3M
Same issuer's Reg CF (Form C) raises
View the original filing on SEC EDGAR ↗